Literature DB >> 22974725

Dual anti-platelet therapy in patients with G6PD deficiency after percutaneous coronary intervention.

Christos Pappas, Konstantina Ntai, John T Parissis, Maria Anastasiou-Nana.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22974725     DOI： 10.1016/j.ijcard.2012.08.024

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  4 in total

Review 1.  Aspirin safety in glucose-6-phosphate dehydrogenase deficiency patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Authors:  Julien Feghaly; Abdul Rahman Al Hout; Mattew Mercieca Balbi
Journal:  BMJ Case Rep       Date:  2017-10-09

Review 2.  Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not?

Authors:  Jianle Li; Yicong Chen; Zilin Ou; Fubing Ouyang; Jiahui Liang; Zimu Jiang; Chunyong Chen; Pingping Li; Jiaxin Chen; Jiating Wei; Jinsheng Zeng
Journal:  Am J Cardiovasc Drugs       Date:  2020-12-14       Impact factor: 3.571

3.  An agent-based model of the response to angioplasty and bare-metal stent deployment in an atherosclerotic blood vessel.

Authors:  Antonia E Curtin; Leming Zhou
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

4.  Association between aspirin-induced hemoglobin decline and outcome after acute ischemic stroke in G6PD-deficient patients.

Authors:  Yicong Chen; Jianle Li; Zilin Ou; Yusheng Zhang; Zhijian Liang; Weisheng Deng; Weixian Huang; Fubing Ouyang; Jian Yu; Shihui Xing; Jinsheng Zeng
Journal:  CNS Neurosci Ther       Date:  2021-08-08       Impact factor: 5.243
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.